Literature DB >> 18025104

Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.

Carla Sampaio1, Marie Dance, Alexandra Montagner, Thomas Edouard, Nicole Malet, Bertrand Perret, Armelle Yart, Jean-Pierre Salles, Patrick Raynal.   

Abstract

Phosphoinositide 3-kinase (PI3K) participates in extracellular signal-regulated kinase 1 and 2 (ERK1-2) activation according to signal strength, through unknown mechanisms. We report herein that Gab1/Shp2 constitutes a PI3K-dependent checkpoint of ERK1-2 activation regulated according to signal intensity. Indeed, by up- and down-regulation of signal strength in different cell lines and through different methods, we observed that Gab1/Shp2 and Ras/ERK1-2 in concert become independent of PI3K upon strong epidermal growth factor receptor (EGFR) stimulation and dependent on PI3K upon limited EGFR activation. Using Gab1 mutants, we observed that this conditional role of PI3K is dictated by the EGFR capability of recruiting Gab1 through Grb2 or through the PI3K lipid product PIP(3), according to a high or weak level of receptor stimulation, respectively. In agreement, Grb2 siRNA generates, in cells with maximal EGFR stimulation, a strong dependence on PI3K for both Gab1/Shp2 and ERK1-2 activation. Therefore, Ras/ERK1-2 depends on PI3K only when PIP(3) is required to recruit Gab1/Shp2, which occurs only under weak EGFR mobilization. Finally, we show that, in glioblastoma cells displaying residual EGFR activation, this compensatory mechanism becomes necessary to efficiently activate ERK1-2, which could probably contribute to tumor resistance to EGFR inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025104      PMCID: PMC2223412          DOI: 10.1128/MCB.01318-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength.

Authors:  B C Duckworth; L C Cantley
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  Structural analysis of autoinhibition in the Ras activator Son of sevenless.

Authors:  Holger Sondermann; Stephen M Soisson; Sean Boykevisch; Shao-Song Yang; Dafna Bar-Sagi; John Kuriyan
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

3.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras.

Authors:  J de Rooij; J L Bos
Journal:  Oncogene       Date:  1997-02-06       Impact factor: 9.867

5.  Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast.

Authors:  S J Isakoff; T Cardozo; J Andreev; Z Li; K M Ferguson; R Abagyan; M A Lemmon; A Aronheim; E Y Skolnik
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

6.  Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

Authors:  D C Schönwasser; R M Marais; C J Marshall; P J Parker
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

7.  Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment.

Authors:  Si Qing Zhang; Wentian Yang; Maria I Kontaridis; Trever G Bivona; Gengyun Wen; Toshiyuki Araki; Jincai Luo; Julie A Thompson; Burkhart L Schraven; Mark R Philips; Benjamin G Neel
Journal:  Mol Cell       Date:  2004-02-13       Impact factor: 17.970

8.  Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.

Authors:  Meng Qiao; Paul Shapiro; Rakesh Kumar; Antonino Passaniti
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

9.  Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 ('Iressa').

Authors:  Baldassarre Stea; Ryan Falsey; Kerri Kislin; Jay Patel; Heather Glanzberg; Steven Carey; Aaron A Ambrad; Emmanuelle J Meuillet; Jesse D Martinez
Journal:  Cancer Lett       Date:  2003-12-08       Impact factor: 8.679

10.  PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors.

Authors:  Enrico K Schmidt; Serge Fichelson; Stephan M Feller
Journal:  BMC Biol       Date:  2004-05-18       Impact factor: 7.431

View more
  23 in total

Review 1.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

2.  Response to erlotinib in recurrent glioblastoma multiforme showing coexpression of EGFRvIII and PTEN.

Authors:  A Custodio; A Calles; P Pérez-Segura
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

3.  Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling.

Authors:  Thomas Edouard; Jean-Philippe Combier; Audrey Nédélec; Sophie Bel-Vialar; Mélanie Métrich; Francoise Conte-Auriol; Stanislas Lyonnet; Béatrice Parfait; Maithé Tauber; Jean-Pierre Salles; Frank Lezoualc'h; Armelle Yart; Patrick Raynal
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

4.  Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.

Authors:  Tilman Brummer; Mark Larance; Maria Teresa Herrera Abreu; Ruth J Lyons; Paul Timpson; Christoph H Emmerich; Emmy D G Fleuren; Gillian M Lehrbach; Daniel Schramek; Michael Guilhaus; David E James; Roger J Daly
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

5.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.

Authors:  Chun Feng Lee; Zhi Qiang Ling; Ting Zhao; Shih Hua Fang; Weng Cheng Chang; San Chih Lee; Kuan Rong Lee
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

6.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

7.  Multiple mechanisms are responsible for transactivation of the epidermal growth factor receptor in mammary epithelial cells.

Authors:  Karin D Rodland; Nikki Bollinger; Danielle Ippolito; Lee K Opresko; Robert J Coffey; Richard Zangar; H Steven Wiley
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

8.  Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.

Authors:  Anne M Deschamps; Elizabeth Murphy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

9.  Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

Authors:  Arkaitz Carracedo; Li Ma; Julie Teruya-Feldstein; Federico Rojo; Leonardo Salmena; Andrea Alimonti; Ainara Egia; Atsuo T Sasaki; George Thomas; Sara C Kozma; Antonella Papa; Caterina Nardella; Lewis C Cantley; Jose Baselga; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

10.  PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras.

Authors:  Ernesto Diaz-Flores; Hana Goldschmidt; Philippe Depeille; Victor Ng; Jon Akutagawa; Kimberly Krisman; Michael Crone; Michael R Burgess; Olusegun Williams; Benjamin Houseman; Kevan Shokat; Deepak Sampath; Gideon Bollag; Jeroen P Roose; Benjamin S Braun; Kevin Shannon
Journal:  Sci Signal       Date:  2013-12-03       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.